This is a condition where certain types of cancer tend to run in families. It means that if you have a family history of cancer, you might have a higher risk of developing it yourself. It's not guaranteed, but it's something doctors look into.
Every report comes from a Lived member, sent anonymously.
Have you had Prophylactic Mastectomy for Hereditary Cancer Syndromes?
A hereditary cancer syndrome is a condition, caused by an inherited change in a single gene, that makes certain cancers much more likely than usual. The change, called a pathogenic variant, sits in a gene that normally helps control cell growth or repair damaged DNA. Because it is present from birth in every cell, a person needs fewer additional changes over a lifetime for a cell to become cancerous. There are many different syndromes, and each raises the risk of its own set of cancers. Hereditary breast and ovarian cancer, caused by variants in the BRCA1 or BRCA2 genes, raises the risk of breast, ovarian and prostate cancer. Lynch syndrome raises the risk of colorectal, endometrial (uterine lining) and several other cancers. Familial adenomatous polyposis (FAP) leads to a very high chance of colorectal cancer at an early age. These syndromes explain only a minority of cancer: about 5% to 10% of all cancers are thought to come from an inherited harmful change. Inheriting one raises risk but does not mean a person will definitely get cancer, and many people who carry a variant never do.
Each syndrome is caused by a variant passed down from a parent through the egg or sperm. Cancer itself is not inherited; what is inherited is the higher risk. Most of the common syndromes, including BRCA-related cancer risk and Lynch syndrome, follow an autosomal dominant pattern: one altered copy of the gene is enough to raise risk, and each child of a carrier has a 50% chance of inheriting it. Men and women can carry and pass on these variants equally. How much risk a variant adds depends on the gene. For example, more than 60% of women with a harmful BRCA1 or BRCA2 variant develop breast cancer during their lifetime, while Lynch syndrome can be caused by any of several genes, some of which carry noticeably higher risks than others. Smoking, alcohol, weight, hormones and age still add to or lower the risk on top of the inherited change. Not every family with several cancers has a syndrome. Shared habits or environment, such as tobacco use, can cause similar cancers among relatives, and common cancers can cluster in a family by chance or from many small genetic effects that no single test identifies.
A diagnosis starts with a careful personal and family history, including which relatives had cancer, what kind and at what age. Patterns that raise suspicion include cancer at a young age (such as colon cancer before 50), more than one cancer in the same person, several relatives with the same cancer or with linked cancers like breast and ovarian or colon and endometrial, cancer in both of a pair of organs, rare cancers such as male breast cancer, and a relative already known to carry a variant. Guidelines also recommend testing for anyone diagnosed with ovarian, pancreatic, metastatic prostate (spread beyond the prostate), triple-negative breast (a type that lacks estrogen, progesterone and HER2 receptors) or male breast cancer, or colorectal cancer before 50. The test itself uses a blood or saliva sample, and results usually take two to three weeks. The standard approach is a panel that checks many cancer genes at once. When possible, testing starts with a relative who has had cancer, because that result tells the rest of the family what to look for. Genetic counseling before testing helps people decide whether and how to test, and counseling afterward explains what a result means for them and their relatives. Results fall into a few categories. A positive result confirms a harmful variant. A true negative means a person did not inherit the variant already found in their family, so their risk is likely close to average. An uninformative negative means nothing was found in a family where no variant is known, so a family history can still justify extra screening. A variant of uncertain significance (VUS) is a change whose effect is not yet known; most are later reclassified as harmless, so a VUS usually should not change care. At-home tests are not a substitute. As of early 2024, the only FDA-authorized consumer test for inherited cancer risk checks three BRCA variants common in people of Ashkenazi Jewish ancestry and misses about 80% of cancer-causing BRCA variants, so a negative result is not reassuring. Genetic testing of a tumor, used to choose cancer treatment, is also different and does not replace testing for an inherited variant.
There is no way to repair an inherited variant, so care focuses on lowering cancer risk and finding cancer early, when it is most treatable. The plan depends on the specific gene, a person's age, sex and health history, and their own priorities. Enhanced screening is the foundation for most syndromes. It usually means starting checks at a younger age and repeating them more often than for the general population, and sometimes adding tests that are not routine. Women with BRCA variants, for example, are generally advised to begin breast screening earlier and to have breast MRI as well as mammograms, and people with Lynch syndrome have colonoscopy earlier and more often. More screening also brings more false alarms and follow-up tests. Risk-reducing surgery removes tissue before cancer can form. For BRCA carriers, removing the ovaries and fallopian tubes lowers the risk of ovarian cancer and possibly breast cancer, and removing both breasts lowers breast cancer risk. These are major decisions with real trade-offs: besides the usual surgical risks of bleeding and infection, removing the ovaries before menopause brings on early menopause, and mastectomy can affect body image. Timing is usually planned around childbearing and the age at which risk rises. Medicines are another option for some people. Tamoxifen, a hormone-blocking drug, can lower breast cancer risk (but not ovarian cancer risk) in some women at increased risk, although how well it works for BRCA carriers specifically is less certain, and its side effects need weighing with a specialist. Not smoking, limiting alcohol, staying active and keeping a healthy weight help lower the risks that genetics do not control. For someone who already has cancer, knowing about an inherited variant can change treatment. Cancers linked to BRCA variants may respond to PARP inhibitors such as olaparib (Lynparza), drugs that exploit the cancer cell's weakened DNA repair, and the result can also shape surgical choices.
Learning that you carry a hereditary cancer syndrome usually means a lifelong plan rather than a single treatment. Many people are followed by a specialist or high-risk clinic that coordinates regular screening, and the plan changes as you age, as research updates the recommendations, and as decisions about surgery or family planning come up. People with a syndrome who never develop cancer often live ordinary lives built around these scheduled checks. The result also reaches beyond you. Sharing it gives parents, siblings and children the chance to test and, if they are negative, to avoid unnecessary screening. When children are tested depends on the syndrome: for adult-onset risks such as BRCA, testing usually waits until age 18 or later, while for syndromes that start in childhood, such as FAP, testing and screening begin in childhood. Relatives may feel differently about whether they want to know, and some people feel guilt about passing on a variant or about being the one who did not inherit it. Genetic counselors and support organizations can help with these conversations, and a care team can help guide decisions about fertility and pregnancy. In the United States, the Genetic Information Nondiscrimination Act (GINA) bars health insurers and employers from using genetic results against you, but it does not cover life, disability or long-term care insurance or members of the military. Some people review those policies before testing. Because genetic knowledge changes, staying in touch with the testing clinic matters, especially after a VUS or a negative result, since findings can be reclassified or newer tests may find something missed before.
Ask your doctor about a genetic counseling referral if you have been diagnosed with one of the cancers for which testing is recommended, if relatives were diagnosed with cancer at unusually young ages or with linked cancers, or if a relative has been found to carry a harmful variant. If you already know you carry one, arrange a visit when your screening schedule lapses, when you are planning a pregnancy, or when you are weighing risk-reducing surgery. Because screening does not catch everything, contact your care team promptly about new symptoms in the organs your syndrome affects rather than waiting for the next scheduled check. For example, that includes a new lump in the breast or armpit, blood in the stool or a lasting change in bowel habits, or abnormal vaginal bleeding for women with Lynch syndrome.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Hereditary Cancer Syndromes is like, what's helped you, or ask the community a question.